CTC Bio Inc. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
123,387
121,855
118,991
123,146
130,559
Cost of Goods Sold (COGS) incl. D&A
91,126
85,820
83,630
91,642
102,404
Gross Income
32,261
36,034
35,360
31,503
28,155
SG&A Expense
29,997
35,623
32,305
33,915
41,955
EBIT
2,120
127
2,492
-
13,996
Unusual Expense
15
53
243
34
7,369
Non Operating Income/Expense
373
78
1,733
1,461
1,085
Interest Expense
1,413
950
1,619
2,109
2,993
Pretax Income
1,859
234
2,971
2,980
23,075
Income Tax
960
3,530
457
241
2,468
Equity in Affiliates
30
212
203
-
-
Consolidated Net Income
928
3,552
2,717
2,739
20,607
Net Income
935
3,502
2,740
2,739
20,603
Net Income After Extraordinaries
1,006
3,502
2,740
2,739
20,603
Net Income Available to Common
935
3,502
2,740
2,739
20,603
EPS (Basic)
55.00
203.00
160.00
160.00
1,192.00
Basic Shares Outstanding
17
17
17
17
17
EPS (Diluted)
50.51
200.61
158.90
159.61
1,191.60
Diluted Shares Outstanding
17
17
17
17
17
EBITDA
4,016
1,976
5,595
994
9,277
Other Operating Expense
144
284
562
208
196
Non-Operating Interest Income
764
614
122
110
193
Minority Interest Expense
7
50
24
-
4
Equity in Affiliates (Pretax)
-
-
-
142
4

About CTC Bio

View Profile
Address
6th Floor, Sambo Building
Seoul SL 05724
Korea, Republic Of
Employees -
Website http://www.ctcbio.com
Updated 09/14/2018
CTC Bio, Inc. engages in the manufacture of pharmaceuticals, functional food and animal health products. It operates through following divisions: Animal Health and Human Medicine. The Animal Health division produces antibiotic, enzyme, probiotic products and bird flu-related diagnostic kits and disinfectants.